Global Rare Disease Genetic Testing Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Global Rare Disease Genetic Testing Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

  • SKU :
    SAC7684033
  • Published Date :
    May 31, 2024
  • Number of Pages :
    300

Product Description

The Rare Disease Genetic Testing market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.

Considering the influence of COVID-19 on the global Rare Disease Genetic Testing market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Rare Disease Genetic Testing Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Rare Disease Genetic Testing market are:
Color Genomics, Inc.
Connective Tissue Gene Tests
Quest Diagnostics Incorporated
Strand Life Sciences
Counsyl, Inc.
PreventionGenetics
Laboratory Corporation of America Holdings
Progenity, Inc.
PerkinElmer Genomics
ARUP Laboratories
Sequenom
Baylor Genetics
Macrogen, Inc.
CooperSurgical, Inc.
Ambry Genetics
Eurofins Scientific
GeneDx
Centogene
Fulgent Genetics Inc.
Invitae Corporation
OPKO Health, Inc.
Bio-Reference Laboratories
3billion, Inc.
Myriad Genetics, Inc.
Genesis Genetics

Most important types of Rare Disease Genetic Testing products covered in this report are:
Neurologic Diseases
Immunologic Disorders
Hematology Diseases
Endocrine & Metabolism Diseases
Cancer
Musculoskeletal Disorders
Cardiovascular Disorders (CVD)
Dermatology Diseases
Other Rare Diseases

Most widely used downstream fields of Rare Disease Genetic Testing market covered in this report are:
Research Laboratories & CROs
Diagnostic Laboratories
Hospitals & Clinics

Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Table of Content 

Table of Content

1 Rare Disease Genetic Testing Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Rare Disease Genetic Testing
1.3 Rare Disease Genetic Testing Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Rare Disease Genetic Testing Revenue and Growth Rate from 2019-2031
1.4 Market Segmentation
1.4.1 Types of Rare Disease Genetic Testing
1.4.2 Applications of Rare Disease Genetic Testing
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Rare Disease Genetic Testing Industry Trends
1.5.2 Rare Disease Genetic Testing Drivers
1.5.3 Rare Disease Genetic Testing Market Challenges
1.5.4 Rare Disease Genetic Testing Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Rare Disease Genetic Testing Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Rare Disease Genetic Testing Industry Development

2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Rare Disease Genetic Testing Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Rare Disease Genetic Testing
2.2.1 Major Players Manufacturing Base of Rare Disease Genetic Testing in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Rare Disease Genetic Testing Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Rare Disease Genetic Testing
2.3.3 Labor Cost of Rare Disease Genetic Testing
2.4 Market Channel Analysis of Rare Disease Genetic Testing
2.5 Major Down Stream Customers by Application

3 Global Rare Disease Genetic Testing Market, by Type
3.1 Global Rare Disease Genetic Testing Revenue and Market Share by Type (2019-2023)
3.2 Global Rare Disease Genetic Testing Production and Market Share by Type (2019-2023)
3.3 Global Rare Disease Genetic Testing Revenue and Growth Rate by Type (2019-2023)
3.3.1 Global Rare Disease Genetic Testing Revenue and Growth Rate of Neurologic Diseases
3.3.2 Global Rare Disease Genetic Testing Revenue and Growth Rate of Immunologic Disorders
3.3.3 Global Rare Disease Genetic Testing Revenue and Growth Rate of Hematology Diseases
3.3.4 Global Rare Disease Genetic Testing Revenue and Growth Rate of Endocrine & Metabolism Diseases
3.3.5 Global Rare Disease Genetic Testing Revenue and Growth Rate of Cancer
3.3.6 Global Rare Disease Genetic Testing Revenue and Growth Rate of Musculoskeletal Disorders
3.3.7 Global Rare Disease Genetic Testing Revenue and Growth Rate of Cardiovascular Disorders (CVD)
3.3.8 Global Rare Disease Genetic Testing Revenue and Growth Rate of Dermatology Diseases
3.3.9 Global Rare Disease Genetic Testing Revenue and Growth Rate of Other Rare Diseases
3.4 Global Rare Disease Genetic Testing Price Analysis by Type (2019-2023)
3.4.1 Explanation of Different Type Product Price Trends

4 Rare Disease Genetic Testing Market, by Application
4.1 Downstream Market Overview
4.2 Global Rare Disease Genetic Testing Consumption and Market Share by Application (2019-2023)
4.3 Global Rare Disease Genetic Testing Consumption and Growth Rate by Application (2019-2023)
4.3.1 Global Rare Disease Genetic Testing Consumption and Growth Rate of Research Laboratories & CROs (2019-2023)
4.3.2 Global Rare Disease Genetic Testing Consumption and Growth Rate of Diagnostic Laboratories (2019-2023)
4.3.3 Global Rare Disease Genetic Testing Consumption and Growth Rate of Hospitals & Clinics (2019-2023)

5 Global Rare Disease Genetic Testing Consumption, Revenue ($) by Region (2019-2023)
5.1 Global Rare Disease Genetic Testing Revenue and Market Share by Region (2019-2023)
5.2 Global Rare Disease Genetic Testing Consumption and Market Share by Region (2019-2023)
5.3 Global Rare Disease Genetic Testing Consumption, Revenue, Price and Gross Margin (2019-2023)
5.4 North America Rare Disease Genetic Testing Consumption, Revenue, Price and Gross Margin (2019-2023)
5.4.1 North America Rare Disease Genetic Testing Market Under COVID-19
5.4.2 North America Rare Disease Genetic Testing SWOT Analysis
5.5 Europe Rare Disease Genetic Testing Consumption, Revenue, Price and Gross Margin (2019-2023)
5.5.1 Europe Rare Disease Genetic Testing Market Under COVID-19
5.5.2 Europe Rare Disease Genetic Testing SWOT Analysis
5.6 China Rare Disease Genetic Testing Consumption, Revenue, Price and Gross Margin (2019-2023)
5.6.1 China Rare Disease Genetic Testing Market Under COVID-19
5.6.2 China Rare Disease Genetic Testing SWOT Analysis
5.7 Japan Rare Disease Genetic Testing Consumption, Revenue, Price and Gross Margin (2019-2023)
5.7.1 Japan Rare Disease Genetic Testing Market Under COVID-19
5.7.2 Japan Rare Disease Genetic Testing SWOT Analysis
5.8 Middle East and Africa Rare Disease Genetic Testing Consumption, Revenue, Price and Gross Margin (2019-2023)
5.8.1 Middle East and Africa Rare Disease Genetic Testing Market Under COVID-19
5.8.2 Middle East and Africa Rare Disease Genetic Testing SWOT Analysis
5.9 India Rare Disease Genetic Testing Consumption, Revenue, Price and Gross Margin (2019-2023)
5.9.1 India Rare Disease Genetic Testing Market Under COVID-19
5.9.2 India Rare Disease Genetic Testing SWOT Analysis
5.10 South America Rare Disease Genetic Testing Consumption, Revenue, Price and Gross Margin (2019-2023)
5.10.1 South America Rare Disease Genetic Testing Market Under COVID-19
5.10.2 South America Rare Disease Genetic Testing SWOT Analysis
5.11 South Korea Rare Disease Genetic Testing Consumption, Revenue, Price and Gross Margin (2019-2023)
5.11.1 South Korea Rare Disease Genetic Testing Market Under COVID-19
5.11.2 South Korea Rare Disease Genetic Testing SWOT Analysis
5.12 Southeast Asia Rare Disease Genetic Testing Consumption, Revenue, Price and Gross Margin (2019-2023)
5.12.1 Southeast Asia Rare Disease Genetic Testing Market Under COVID-19
5.12.2 Southeast Asia Rare Disease Genetic Testing SWOT Analysis

6 Global Rare Disease Genetic Testing Production by Top Regions (2019-2023)
6.1 Global Rare Disease Genetic Testing Production by Top Regions (2019-2023)
6.2 North America Rare Disease Genetic Testing Production and Growth Rate
6.3 Europe Rare Disease Genetic Testing Production and Growth Rate
6.4 China Rare Disease Genetic Testing Production and Growth Rate
6.5 Japan Rare Disease Genetic Testing Production and Growth Rate
6.6 India Rare Disease Genetic Testing Production and Growth Rate

7 Global Rare Disease Genetic Testing Consumption by Regions (2019-2023)
7.1 Global Rare Disease Genetic Testing Consumption by Regions (2019-2023)
7.2 North America Rare Disease Genetic Testing Consumption and Growth Rate
7.3 Europe Rare Disease Genetic Testing Consumption and Growth Rate
7.4 China Rare Disease Genetic Testing Consumption and Growth Rate
7.5 Japan Rare Disease Genetic Testing Consumption and Growth Rate
7.6 Middle East & Africa Rare Disease Genetic Testing Consumption and Growth Rate
7.7 India Rare Disease Genetic Testing Consumption and Growth Rate
7.8 South America Rare Disease Genetic Testing Consumption and Growth Rate
7.9 South Korea Rare Disease Genetic Testing Consumption and Growth Rate
7.10 Southeast Asia Rare Disease Genetic Testing Consumption and Growth Rate

8 Competitive Landscape
8.1 Competitive Profile
8.2 Color Genomics, Inc. Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.2.3 Color Genomics, Inc. Sales, Revenue, Price, Gross Margin 2019-2023
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Connective Tissue Gene Tests Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.3.3 Connective Tissue Gene Tests Sales, Revenue, Price, Gross Margin 2019-2023
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Quest Diagnostics Incorporated Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.4.3 Quest Diagnostics Incorporated Sales, Revenue, Price, Gross Margin 2019-2023
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Strand Life Sciences Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.5.3 Strand Life Sciences Sales, Revenue, Price, Gross Margin 2019-2023
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Counsyl, Inc. Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.6.3 Counsyl, Inc. Sales, Revenue, Price, Gross Margin 2019-2023
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 PreventionGenetics Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.7.3 PreventionGenetics Sales, Revenue, Price, Gross Margin 2019-2023
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Laboratory Corporation of America Holdings Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.8.3 Laboratory Corporation of America Holdings Sales, Revenue, Price, Gross Margin 2019-2023
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Progenity, Inc. Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.9.3 Progenity, Inc. Sales, Revenue, Price, Gross Margin 2019-2023
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 PerkinElmer Genomics Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.10.3 PerkinElmer Genomics Sales, Revenue, Price, Gross Margin 2019-2023
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 ARUP Laboratories Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.11.3 ARUP Laboratories Sales, Revenue, Price, Gross Margin 2019-2023
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19
8.12 Sequenom Market Performance Analysis
8.12.1 Company Profiles
8.12.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.12.3 Sequenom Sales, Revenue, Price, Gross Margin 2019-2023
8.12.4 Company Recent Development
8.12.5 Strategies for Company to Deal with the Impact of COVID-19
8.13 Baylor Genetics Market Performance Analysis
8.13.1 Company Profiles
8.13.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.13.3 Baylor Genetics Sales, Revenue, Price, Gross Margin 2019-2023
8.13.4 Company Recent Development
8.13.5 Strategies for Company to Deal with the Impact of COVID-19
8.14 Macrogen, Inc. Market Performance Analysis
8.14.1 Company Profiles
8.14.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.14.3 Macrogen, Inc. Sales, Revenue, Price, Gross Margin 2019-2023
8.14.4 Company Recent Development
8.14.5 Strategies for Company to Deal with the Impact of COVID-19
8.15 CooperSurgical, Inc. Market Performance Analysis
8.15.1 Company Profiles
8.15.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.15.3 CooperSurgical, Inc. Sales, Revenue, Price, Gross Margin 2019-2023
8.15.4 Company Recent Development
8.15.5 Strategies for Company to Deal with the Impact of COVID-19
8.16 Ambry Genetics Market Performance Analysis
8.16.1 Company Profiles
8.16.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.16.3 Ambry Genetics Sales, Revenue, Price, Gross Margin 2019-2023
8.16.4 Company Recent Development
8.16.5 Strategies for Company to Deal with the Impact of COVID-19
8.17 Eurofins Scientific Market Performance Analysis
8.17.1 Company Profiles
8.17.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.17.3 Eurofins Scientific Sales, Revenue, Price, Gross Margin 2019-2023
8.17.4 Company Recent Development
8.17.5 Strategies for Company to Deal with the Impact of COVID-19
8.18 GeneDx Market Performance Analysis
8.18.1 Company Profiles
8.18.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.18.3 GeneDx Sales, Revenue, Price, Gross Margin 2019-2023
8.18.4 Company Recent Development
8.18.5 Strategies for Company to Deal with the Impact of COVID-19
8.19 Centogene Market Performance Analysis
8.19.1 Company Profiles
8.19.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.19.3 Centogene Sales, Revenue, Price, Gross Margin 2019-2023
8.19.4 Company Recent Development
8.19.5 Strategies for Company to Deal with the Impact of COVID-19
8.20 Fulgent Genetics Inc. Market Performance Analysis
8.20.1 Company Profiles
8.20.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.20.3 Fulgent Genetics Inc. Sales, Revenue, Price, Gross Margin 2019-2023
8.20.4 Company Recent Development
8.20.5 Strategies for Company to Deal with the Impact of COVID-19
8.21 Invitae Corporation Market Performance Analysis
8.21.1 Company Profiles
8.21.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.21.3 Invitae Corporation Sales, Revenue, Price, Gross Margin 2019-2023
8.21.4 Company Recent Development
8.21.5 Strategies for Company to Deal with the Impact of COVID-19
8.22 OPKO Health, Inc. Market Performance Analysis
8.22.1 Company Profiles
8.22.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.22.3 OPKO Health, Inc. Sales, Revenue, Price, Gross Margin 2019-2023
8.22.4 Company Recent Development
8.22.5 Strategies for Company to Deal with the Impact of COVID-19
8.23 Bio-Reference Laboratories Market Performance Analysis
8.23.1 Company Profiles
8.23.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.23.3 Bio-Reference Laboratories Sales, Revenue, Price, Gross Margin 2019-2023
8.23.4 Company Recent Development
8.23.5 Strategies for Company to Deal with the Impact of COVID-19
8.24 3billion, Inc. Market Performance Analysis
8.24.1 Company Profiles
8.24.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.24.3 3billion, Inc. Sales, Revenue, Price, Gross Margin 2019-2023
8.24.4 Company Recent Development
8.24.5 Strategies for Company to Deal with the Impact of COVID-19
8.25 Myriad Genetics, Inc. Market Performance Analysis
8.25.1 Company Profiles
8.25.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.25.3 Myriad Genetics, Inc. Sales, Revenue, Price, Gross Margin 2019-2023
8.25.4 Company Recent Development
8.25.5 Strategies for Company to Deal with the Impact of COVID-19
8.26 Genesis Genetics Market Performance Analysis
8.26.1 Company Profiles
8.26.2 Rare Disease Genetic Testing Product Profiles, Application and Specification
8.26.3 Genesis Genetics Sales, Revenue, Price, Gross Margin 2019-2023
8.26.4 Company Recent Development
8.26.5 Strategies for Company to Deal with the Impact of COVID-19

9 Global Rare Disease Genetic Testing Market Analysis and Forecast by Type and Application
9.1 Global Rare Disease Genetic Testing Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Neurologic Diseases Market Revenue and Volume Forecast (2021-2026)
9.1.2 Immunologic Disorders Market Revenue and Volume Forecast (2021-2026)
9.1.3 Hematology Diseases Market Revenue and Volume Forecast (2021-2026)
9.1.4 Endocrine & Metabolism Diseases Market Revenue and Volume Forecast (2021-2026)
9.1.5 Cancer Market Revenue and Volume Forecast (2021-2026)
9.1.6 Musculoskeletal Disorders Market Revenue and Volume Forecast (2021-2026)
9.1.7 Cardiovascular Disorders (CVD) Market Revenue and Volume Forecast (2021-2026)
9.1.8 Dermatology Diseases Market Revenue and Volume Forecast (2021-2026)
9.1.9 Other Rare Diseases Market Revenue and Volume Forecast (2021-2026)
9.2 Global Rare Disease Genetic Testing Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Research Laboratories & CROs Market Revenue and Volume Forecast (2021-2026)
9.2.2 Diagnostic Laboratories Market Revenue and Volume Forecast (2021-2026)
9.2.3 Hospitals & Clinics Market Revenue and Volume Forecast (2021-2026)

10 Rare Disease Genetic Testing Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Rare Disease Genetic Testing Market Trends Analysis

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
 

Search results for Medical Devices Industry

Select License Type

get a sample
Ask For Customization
Get a quote
Speak to Analyst
Buy Now

Pharmaceutical

Travel & Leisure

Defense and Aeronautics

Top Rated Products